Skip to content Skip to footer

PharmaShots Magazine-November-2025 Edition

Radiopharmaceuticals, once viewed as a niche scientific endeavor, are now revolutionizing the way we detect and treat cancer. By fusing the targeting precision of molecular medicine with the therapeutic strength of radiation, these compounds are unlocking new possibilities in oncology, bringing renewed hope to patients where conventional therapies often fall short From early detection to…

Read more

Top 20 Oncology Companies of 2025 

Shots:  ADCs, cell therapies, and radioligand therapies are reshaping oncology, while biopharma companies focus on smarter trials, patient-first approaches, and faster access to bridge unmet needs in cancer care  In 2024, the global oncology market was valued at $225.01B and is projected to reach $668.26B by 2034, reflecting a strong CAGR of 11.5% from 2025…

Read more

Thoughtspot_Selina-Gran

Bridging the Gap Between Conventional and Integrative Medicine

Conventional medicine plays a crucial role in diagnosing, treating, and managing diseases through evidence-based interventions, including medications, surgeries, and other standardized treatments. However, there is a growing interest in integrative medicine, which combines conventional treatments with scientifically backed complementary therapies. This shift reflects a broader movement toward patient-centered, holistic healthcare that prioritizes both symptom relief…

Read more